CAROLINA GOICH: Open Payments
NPI 1124132063 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 78 payments from 13 companies in 2025. Trend: 2023 $744 · 2024 $1,257 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $318 |
| GlaxoSmithKline, LLC. | 22 | $257 |
| Pulmonx Corporation | 2 | $237 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $206 |
| Verona Pharma, Inc. | 11 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Mallinckrodt Hospital Products Inc. | 4 | $91 |
| PFIZER INC. | 3 | $63 |
| GENZYME CORPORATION | 3 | $54 |
| Grifols USA, LLC | 2 | $34 |
Products named: CHARTIS CATHETER, NUCALA, Ohtuvayre, BREZTRI, JASCAYD, OFEV, GLASSIA, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
